Pure Global

IMBRUVICA 280 MG FILM COATED TABLET, 30 PCS - Turkey License 7f9e1a1ebebeddd19d0f0ad30ec14a49

Access comprehensive regulatory information for IMBRUVICA 280 MG FILM COATED TABLET, 30 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 7f9e1a1ebebeddd19d0f0ad30ec14a49 with license number 2022/478and contains active ingredient İbrutinib. The license is held by JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
7f9e1a1ebebeddd19d0f0ad30ec14a49
License Details
Turkey SFDA License: 7f9e1a1ebebeddd19d0f0ad30ec14a49
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

IMBRUVICA 280 MG FILM COATED TABLET, 30 PCS
TR: IMBRUVİCA 280 MG FİLM KAPLI TABLET, 30 ADET
Pharmaceutical Product

License Details

7f9e1a1ebebeddd19d0f0ad30ec14a49

2022/478

8699593095597

L01EL01

License Holder Information

Active Ingredient

İbrutinib

License Information

Aug 25, 2022